PA
OMDA

PharVision Advisers’s Omada Health Inc OMDA Stock Holding History

PharVision Advisers’s Portfolio OMDA Stock Details OMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,415
Closed -$385K – 699
2025
Q4 		$385K Buy
+24,415
New +$495K 0.2% 144

Other funds holding OMDA

DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $110M AUM
CI
Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

PharVision Advisers's OMDA Position: Q1 2026 in Review

PharVision Advisers sold out of Omada Health Inc (OMDA) in Q1 2026, closing a stake of 24,415 shares — an estimated $385K sold.

PharVision Advisers first reported a position in OMDA in Q4 2025 and held it in 1 quarter. The position peaked at $385K in Q4 2025. 139 funds tracked by Wall St. Rank hold OMDA as of Q1 2026.

  • PharVision Advisers reported no remaining Omada Health Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 24,415 Omada Health Inc shares in Q1 2026, an estimated $385K.
  • PharVision Advisers first reported a position in Omada Health Inc in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Omada Health Inc position peaked at $385K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Omada Health Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.